BackMapLight Therapeutics Overview
MapLight Therapeutics, Inc.

MapLight Therapeutics Target Price

Analysts' 12-month price predictions for MPLT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$30.1

Average Target Price

$45.3350.6% upside

3 analysts in the last 4 months

High: $48 | Low: $43

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-26UBSAshwani Verma$4859.5% upsideOpen
2026-05-21Craig-HallumAdam Vogel$4342.9% upsideOpen
2026-05-04H.C. WainwrightRaghuram Selvaraju$4549.5% upsideOpen
2025-11-21Leerink PartnersMarc Goodman$300.3% downsideOpen
2025-11-21JefferiesAndrew Tsai$326.3% upsideOpen
2025-11-21Stifel Nicolaus$287% downsideOpen
2025-11-21Morgan Stanley$3413% upsideOpen